Valeriana officinalis
Valeriana officinalis
Valeriana officinalis

Plant Family
Caprifoliaceae
Botanical Description
Valerian is a perennial herb growing 1-1.5 meters tall with pinnate leaves and clusters of small, sweetly fragrant pink or white flowers from June to August. The root has a distinctive pungent odor, especially when dried.
Cautions
Generally safe for short-term use. May cause headaches, digestive upset, or dizziness. Do not combine with sedatives, alcohol, or sleep medications. Not recommended during pregnancy or breastfeeding. May cause paradoxical stimulation in some people.
Habitat
Damp meadows, woodland edges, stream banks. Often cultivated in gardens.
Harvest Instructions
Roots harvested in autumn from plants at least 2 years old. Dig carefully to preserve root mass. Clean and dry at low temperatures.
Geographic Distribution
Native to Europe and parts of Asia. Widely cultivated worldwide. Naturalized in North America.
Growth Conditions
Prefers moist, fertile soil. Full sun to partial shade. Hardy perennial.
Plant Size
100-150 cm
Pests & Diseases
May be affected by aphids and fungal root diseases in wet conditions.
Effects on the Body
Calms the nervous system, promotes sleep, reduces anxiety, relaxes muscle spasms. One of the most researched herbal sedatives.
Active Constituents
Valerenic acid, isovaleric acid, iridoids (valepotriates), sesquiterpenes, flavonoids, GABA.
Safety Information
Pregnancy Safety: avoid
Breastfeeding Safety: avoid
Children Safety: 12_plus
Dosage
Tea: 2-3 g dried root in hot water, steep 10-15 minutes, take before bed. Tincture: 2-4 ml before bed. Capsules: 300-600 mg standardized extract.
Culinary Use
Not used culinarily due to strong odor and taste.
Folklore & Historical Use
Used since ancient Greek and Roman times. Called 'all-heal' in medieval Europe. Used during World War I and II to treat shell shock and nervous conditions.
Scientific Research
Extensive clinical research supports use for sleep and anxiety. A 2006 meta-analysis of 16 trials showed improved sleep quality without morning drowsiness. European Medicines Agency and German Commission E approve for nervousness and sleep disorders.
Jóna Lilja Guðjónsdóttir